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Abstract. 
 
A morphogenesis checkpoint in budding 
yeast delays cell cycle progression in response to per-
turbations of cell polarity that prevent bud formation 
(Lew, D.J., and S.I. Reed. 1995. 
 
J. Cell Biol.
 
 129:739–
749). The cell cycle delay depends upon the tyrosine
kinase Swe1p, which phosphorylates and inhibits the 
cyclin-dependent kinase Cdc28p (Sia, R.A.L., H.A. 
Herald, and D.J. Lew. 1996. 
 
Mol
 
.
 
 Biol
 
.
 
 Cell.
 
 7:1657–
1666). In this report, we have investigated the nature of 
the defect(s) that trigger this checkpoint. A Swe1p-
dependent cell cycle delay was triggered by direct per-
turbations of the actin cytoskeleton, even when polarity 
establishment functions remained intact. Furthermore, 
actin perturbation could trigger the checkpoint even in 
cells that had already formed a bud, suggesting that the 
checkpoint directly monitors actin organization, rather 
than (or in addition to) polarity establishment or bud 
formation. In addition, we show that the checkpoint 
could detect actin perturbations through most of the 
cell cycle. However, the ability to respond to such per-
turbations by delaying cell cycle progression was re-
stricted to a narrow window of the cell cycle, delimited 
by the periodic accumulation of the checkpoint effec-
tor, Swe1p.
Key words: checkpoint • actin • SWE1 • morphogen-
esis • cell cycle
 
P
 
ROLIFERATING
 
 cells must coordinate cell cycle events
so that they occur in the proper order with respect
to each other. Insight into how disparate processes
such as DNA replication, spindle formation, and cytokine-
sis are coordinated came from the discovery of surveil-
lance pathways called checkpoint controls (Hartwell and
Weinert, 1989; Murray, 1992). Checkpoint controls are
regulatory pathways that monitor the progress of key cell
cycle events and act to delay cell cycle progression if those
events have not been satisfactorily completed. For in-
stance, the DNA replication checkpoint delays entry into
mitosis until DNA replication is complete, whereas the
spindle assembly checkpoint delays anaphase onset until
all of the chromosomes are properly oriented on the mi-
totic spindle. Thus, checkpoint controls ensure that cell cy-
cle events occur in the proper order even if some perturba-
tion delays performance of a particular event.
How do checkpoint controls sense the progress of cell
cycle events? The DNA replication checkpoint is thought
to monitor the status of DNA replication forks; these are
disassembled when DNA replication is complete, so their
presence indicates incomplete (or stalled) DNA replica-
tion, prompting the checkpoint to delay cell cycle progres-
 
sion (Li and Deshaies, 1993; Navas
 
 
 
et al., 1995). The spin-
dle assembly checkpoint appears to monitor the status of
kinetochores on mitotic chromosomes: the composition of
kinetochores changes upon attachment to the spindle
(Nicklas
 
 
 
et al., 1995; Wells, 1996), so the presence of unat-
tached (or improperly attached) kinetochores indicates in-
complete spindle assembly, prompting the checkpoint to
delay cell cycle progression.
A slightly different checkpoint paradigm is provided by
the DNA damage checkpoint. Rather than monitoring a
particular cell cycle event, this checkpoint monitors DNA
damage, which can occur as a result of extrinsic factors at
any time in the cell cycle. Depending on the time within
the cell cycle at which the DNA damage is incurred, the
checkpoint can exert different effects on cell cycle pro-
gression, promoting a delay in G1, a slowing of S phase, a
G2 arrest, or even a pause in midanaphase (Weinert and
Hartwell, 1988; Siede
 
 
 
et al., 1993; Paulovich and Hartwell,
1995; Yang
 
 
 
et al., 1997; for review see Lew
 
 
 
et al., 1997).
These delays are thought to preserve genome integrity by
allowing time for repair of the damage before cell cycle
events like DNA replication or chromosome segregation
render the damage unrepairable.
In yeast, a morphogenesis checkpoint delays nuclear di-
vision when cell polarity is perturbed (Lew and Reed,
1995
 
a
 
). Environmental stresses, such as increases in tem-
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perature or osmolarity, cause a temporary disruption of
cytoskeletal polarity and delay bud formation (Chowdhury
et al., 1992; Lillie and Brown, 1994). During this delay, cell
cycle progression is halted, preventing the accumulation of
binucleate cells. The cell cycle arrest is due to inhibitory
phosphorylation of the master cell cycle regulatory cyclin-
dependent kinase, Cdc28p, at tyrosine 19 (Lew and Reed,
1995
 
a
 
). This lowers the activity of G2 cyclin–Cdc28p com-
plexes, preventing nuclear division. Phosphorylation of
Cdc28p is catalyzed by the protein kinase Swe1p (Booher
et al., 1993); cells lacking Swe1p are unable to delay mito-
sis in response to depolarizing conditions and thus become
binucleate (Sia
 
 
 
et al., 1996). The structure(s) monitored by
the morphogenesis checkpoint has not yet been described
and forms the subject of this report.
Unbudded yeast cells in G1 are triggered to initiate bud
formation by the activation of G1 cyclin–Cdc28p com-
plexes (Cdc28p is homologous to cdc2 in fission yeast)
(Lew and Reed, 1993). Bud formation also requires the ac-
tivation (GTP loading) of the Rho-family GTPase, Cdc42p,
catalyzed by the guanine nucleotide exchange factor
Cdc24p (Fig. 1) (Pringle
 
 
 
et al., 1995). In a manner that is
poorly understood, activation of Cdc28p and Cdc42p leads
to polarization of the actin cytoskeleton, assembly of sep-
tin filaments, and polarization of various cortical proteins
towards a “prebud site” from which the bud will emerge
(Fig. 1). This site is dictated by positional information en-
coded and interpreted by a set of “bud site selection”
genes (Fig. 1) (Pringle
 
 
 
et al., 1995). Polarized actin cables
are thought to provide tracks along which secretory vesi-
cles are delivered to the prebud site (Novick and Botstein,
1985), and septin filaments are thought to provide scaf-
folds for the local activation of specific cell wall synthesis
enzymes (DeMarini
 
 
 
et al., 1997). Together, the polariza-
tion of secretory and cell wall synthetic activities result in
bud formation (Fig. 1).
In previous studies, the morphogenesis checkpoint was
investigated primarily through the use of temperature-sen-
sitive 
 
cdc24
 
 and 
 
cdc42
 
 mutants (Lew and Reed, 1995
 
a
 
; Sia
et al., 1996). At the restrictive temperature, these mutants
prevent activation of Cdc42p, and hence polarization of all
cytoskeletal elements, leading to a failure in bud forma-
tion (Adams
 
 
 
et al., 1990). Since so many events were
blocked in these mutants, it was impossible to distinguish
whether the checkpoint monitored an upstream event in
polarity establishment (such as GTP loading of Cdc42p),
an intermediate step (such as actin polarization), or the fi-
nal outcome (the presence or size of a bud). In this report,
we have used a panel of other mutants as well as the actin
depolymerizing drug latrunculin-A (Lat-A)
 
1
 
 to investigate
the defect monitored by the morphogenesis checkpoint.
The results suggest that the checkpoint monitors actin or-
ganization. Furthermore, while perturbation of actin can
be detected by the checkpoint throughout the period of
bud formation, it is only translated into a cell cycle delay if
the perturbation occurs during the critical early phase of
bud formation. This restriction is due to the periodic ex-
pression of the checkpoint effector, Swe1p.
 
Materials and Methods
 
Reagents
 
Rhodamine-conjugated phalloidin was purchased from Molecular Probes
(Eugene, OR) and stored as a 200 U/ml stock solution in methanol at
 
2
 
20
 
8
 
C. 4
 
9
 
6
 
9
 
-diamidino-2-phenylindole (DAPI) was purchased from Sigma
Chemical Co. (St. Louis, MO) and stored as a 1 mg/ml stock solution in
H
 
2
 
O at 
 
2
 
20
 
8
 
C. Lat-A was initially provided as a generous gift by David
Drubin (University of California, Berkeley, CA) and subsequently pur-
chased from Molecular Probes and stored as a 20 mM stock solution in
dimethylsulfoxide at 
 
2
 
20
 
8
 
C. 9E10 monoclonal anti-myc antibody was pur-
chased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Mono-
clonal anti-PSTAIRE antibody was a gift from Dr. Steven Reed (The
Scripps Research Institute, La Jolla, CA). HRP-conjugated goat anti–
mouse secondary antibody was purchased from Jackson ImmunoRe-
search Laboratories, Inc. (West Grove, PA). Mounting medium was made
as described (Pringle
 
 
 
et al., 1991).
 
Yeast Strains, Growth Conditions, and Cell Synchrony
 
The yeast strains used in this study are listed in Table I. All are in the
BF264-15DU background (
 
ade1
 
,
 
 his2
 
,
 
 leu2-3
 
,
 
112
 
,
 
 trp1-1
 
a
 
,
 
 ura3
 
D
 
ns
 
). Gene
disruptions (
 
cap2::URA3
 
 [Cannon and Tatchell, 1987; Amatruda
 
 
 
et al., 1990],
 
tpm1::URA3
 
 [Liu and Bretscher, 1989], 
 
sac6::URA3
 
 [Adams
 
 
 
et al., 1991],
 
swe1::LEU2
 
 [Booher
 
 
 
et al., 1993], and 
 
mih1::LEU2
 
 [Russell et al., 1989])
and the 
 
GAP::SWE1
 
 allele (Sia
 
 
 
et al., 1996) were constructed by direct
transformation into the BF264-15DU background. Other alleles (
 
myo2-66
 
[Johnston
 
 
 
et al., 1991], 
 
pfy1-111::LEU2
 
 [Haarer
 
 
 
et al., 1993], and 
 
cdc15-2
 
[Hartwell
 
 
 
et al., 1974]) were serially backcrossed a minimum of six times
into the BF264-15DU background.
The 
 
SWE1-myc
 
 construct was generated as follows: a 3.7-kb XbaI-
BamHI fragment from pSWE1-HA (Booher et al., 1993) containing
 
GAL1-SWE1-HA
 
 was cloned into an altered version of pRS306 (Sikorski
and Hieter, 1989), which had the polylinker sites from KpnI to SmaI de-
leted. The NheI site in the HA tag sequence was converted into a SalI site
using the linker oligonucleotide 5
 
9
 
-CTAGCGTCGACA-3
 
9
 
, and a 400-bp
XhoI-SalI fragment containing 12 tandem copies of the myc epitope (Paul
Russell, The Scripps Research Institute) was cloned into the SalI site. To
create the 
 
SWE1-myc
 
 strain RSY206, the construct was digested with
KpnI, which cuts near the COOH terminus of 
 
SWE1
 
, directing integration
at the 
 
SWE1
 
 locus in yeast. This results in a tagged 
 
SWE1
 
 on its own pro-
moter, with an adjacent 
 
URA3
 
 marker and 
 
GAL1::SWE1
 
 (untagged; this
is not relevant to the experiment of Fig. 7, which was carried out in dex-
trose-containing media). To tag the 
 
GAP::SWE1
 
 construct, we used a de-
 
1. 
 
Abbreviations used in this paper
 
: DAPI, 4
 
9
 
6
 
9
 
-diamidino-2-phenylindole;
Lat-A, latrunculin-A.
Figure 1. Establishment of
cell polarity in yeast. Bud site
selection genes establish a fu-
ture bud site at a location
that depends on the mating
type of the cell. Cdc42p be-
comes concentrated at that
site and promotes the polar-
ization of the actin cytoskele-
ton towards that site, as well
as the assembly of septin fila-
ments and the concentration
of cortical proteins (e.g.,
Spa2p) at that site. 10–20 min
after polarization, the cells
make a visible bud, which
then grows through directed
secretion dependent upon
polarized actin (for reviews
see Lew and Reed, 1995b;
Pringle et al., 1995; Lew et
al., 1997). 
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rivative of the plasmid above, deleted for sequences between the XbaI
and ClaI, lacking the GAL promoter and NH
 
2
 
-terminal two thirds of
 
SWE1
 
. This was digested with KpnI and integrated into a 
 
swe1
 
D
 
 GAP::
SWE1
 
 strain. The resulting strain (RSY255) contains a single copy of
 
GAP::SWE1-myc
 
 and an adjacent truncated promoterless 
 
SWE1
 
 frag-
ment. The same strategy was used to make the 
 
SWE1-myc
 
 allele in strain
RSY311, except the above KpnI-digested plasmid was transformed into a
strain containing only the wild-type allele of 
 
SWE1
 
. RSY311 contains a
single copy of 
 
SWE1-myc
 
 and an adjacent truncated promoterless 
 
SWE1
 
.
A plasmid containing 
 
GAL1::MIH1
 
, pJM1016, was isolated from a
GAL1::cDNA library (Liu et al., 1992). This clone contains the entire cod-
ing region of 
 
MIH1
 
 as well as seven bases upstream of the 
 
MIH1
 
 start
codon. A KpnI/PstI fragment from pJM1016 containing the GAL1 pro-
moter and the first 0.76 kb of 
 
MIH1
 
 were ligated into the KpnI/PstI site of
the 
 
TRP1
 
 integrating vector pRS304 (Sikorski and Hieter, 1989), creating
pJM1022. pJM1022 was digested with BglII (internal to 
 
MIH1
 
) and trans-
formed into yeast. Integration at the genomic 
 
MIH1
 
 locus generates a full-
length 
 
MIH1
 
 under control of the 
 
GAL1
 
 promoter and an adjacent trun-
cated 
 
mih1
 
 (3
 
9
 
 deleted). Integration was confirmed phenotypically by
crossing to a 
 
GAL1::SWE1
 
 strain. 
 
GAL1::MIH1
 
 rescues the lethality of a
 
GAL1::SWE1
 
 strain grown on galactose media.
Cells were grown in rich medium (YEPD: 1% yeast extract, 2% bacto-
peptone, 2% dextrose, 0.01% adenine) at 30
 
8
 
C, except where indicated.
For pheromone arrest/release experiments, exponentially growing cells
(2–5 
 
3 
 
10
 
6
 
 cells/ml) in YEPD were incubated with 20–25 ng/ml 
 
a
 
-factor
for 2 h, harvested by centrifugation, washed once with YEPD, and resus-
pended in fresh YEPD to release from the 
 
a
 
-factor–induced cell cycle
block. 
 
bar1
 
 strains were used in all of the 
 
a
 
-factor synchrony experiments
except for the 
 
myo2-66
 
 strains in Fig. 3 
 
A
 
, which are 
 
BAR1
 
 and were syn-
chronized with 2 
 
m
 
g/ml 
 
a
 
-factor.
 
Yeast Lysates and Immunoblotting
 
Yeast cells were washed with ice-cold H
 
2
 
O and harvested by centrifuga-
tion. Pellets were stored frozen at 
 
2
 
80
 
8
 
C. Lysates were made by resus-
pending pellets in a buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 5 mM EDTA, 1% NP-40, 1 mM sodium pyrophosphate, 1 mM
PMSF, 1 mM sodium orthovanadate, and 2 
 
m
 
g/ml each of aprotinin, pep-
statin A, and leupeptin, and vortexing with acid-washed glass beads. Ly-
sates were clarified by centrifugation (8 min, 14,000 rpm in an Eppendorf
centrifuge [Madison, WI]), and the protein concentration was determined
by the Bio-Rad assay (Hercules, CA). 50 
 
m
 
g of total protein (per gel lane)
from each lysate was mixed with hot (95
 
8
 
C) 2
 
3 
 
sample loading buffer (fi-
nal concentrations 62.5 mM Tris-HCl, pH 6.8, 1% SDS, 25% glycerol, 355
mM 
 
b
 
-mercaptoethanol, and 0.01% bromophenol blue) and incubated at
95
 
8
 
C for 5 min before running on a 10% polyacrylamide gel. After stan-
dard SDS-PAGE, proteins were transferred to immobilon transfer mem-
brane (Millipore Corp., Bedford, MA), and the membrane was cut in two.
The upper half was immunoblotted with anti-myc antibody and the bot-
tom half with anti-PSTAIRE antibody (this recognizes Cdc28p and
Pho85p). Membranes were first blocked in 5% dry milk in PBS with 0.1%
Tween (PBS/Tween). Primary antibodies were used at 1:1,000 dilution
(anti-myc) or 1:25,000 dilution (anti-PSTAIRE) in 1% milk/PBS-Tween.
Secondary antibody was used at 1:2,500 dilution in PBS/Tween. All incu-
bations were carried out for 1 h and separated by three washes with PBS/
Tween. Blots were developed using the Renaissance Western Blot Chemi-
luminescence Reagent Plus (NEN™ Life Sciences Products, Boston, MA).
For the quantitative immunoblots in Fig. 8 
 
C
 
, asynchronous cultures of
strains containing myc-tagged Swe1p expressed from its own promoter
(RSY311, 
 
top
 
) or the 
 
GAP
 
 promoter (RSY255, 
 
middle
 
), as well as a con-
trol with no tagged Swe1p (DLY1, 
 
bottom
 
), were lysed, and the indicated
amounts of lysate were spotted onto nitrocellulose and processed for
immunoblotting with anti-myc or anti-PSTAIRE (loading control) anti-
bodies. The ratio of myc to PSTAIRE signal was quantitated by scanning
densitometry using a Molecular Dynamics Personal Densitometer SI
(Sunnyvale, CA) and ImageQuant v1.2 software.
 
Fluorescence Staining and Microscopy
 
DNA was visualized by staining with DAPI. Cells were fixed by the addi-
tion of two volumes of 95% EtOH directly to the yeast culture, followed
by incubation for 30 min at room temperature or 
 
.
 
12 h at 4
 
8C. Cells were
harvested by centrifugation and resuspended in 0.4 mg/ml DAPI in H2O.
F-actin was visualized by staining with rhodamine-conjugated phalloidin.
Cells were fixed in ice-cold 70% EtOH for 15 min, harvested, washed, and
resuspended in 20 U/ml rhodamine-conjugated phalloidin in PBS. The
cells were then incubated for 30 min at room temperature, harvested, and
washed three times with PBS. After the final wash, cells were resuspended
in mounting media. Stained cells were viewed on a microscope (model
Axioscope; Carl Zeiss, Inc., Thornwood, NY) equipped with epifluores-
cent and Nomarski optics. Images were captured using a Pentamax cooled
CCD camera (Princeton Instruments, Princeton, NJ).
Spot Assays
To compare the growth of different strains, cells were sonicated and
counted on a hemacytometer. For each strain, four 2-ml spots were pipet-
ted onto a YEPD plate, each spot containing a total of z1,250, 250, 50, or
10 cells, respectively. Strains being compared were pipetted onto the same
plate. We found that many of our strains accumulated spontaneous sup-
pressor mutations at quite high rates. It may be that any mutation that
slows cell cycle progression would constitute a “suppressor” of a strain in
which insufficient time is allowed for bud formation before mitosis; such
suppressors might arise quite frequently and be strongly selected for in
our strains. In an attempt to avoid this problem, heterozygous diploid
strains were sporulated and dissected. Cells from haploid colonies were
picked directly from the dissection plates and spotted as above, minimiz-
ing the selection of spontaneous “fast-growing” mutants. The tempera-
ture-sensitive myo2-66 and myo2-66 swe1::LEU2 strains, which can be
maintained at the permissive temperature of 238C, were the only excep-
tion to this strategy. Pictures of the plates were taken 2–3 d after spotting
of the cells.
cap2::URA3 and cap2::URA3 swe1::LEU2 strains were obtained from
the sporulation of the diploid strain JMY1233. tpm1::URA3 strains were
obtained from the sporulation of JMY1188, and tpm1::URA3 swe1::LEU2
were obtained from the diploid JMY1169. sac6::URA3 and sac6::URA3
swe1::LEU2 were spore isolates of JMY1215 and JMY1216, respectively,
and the haploids pfy1-111:LEU2 and pfy1-111:LEU2 swe1::LEU2 were
isolated from the sporulation of JMY1196.
Viability Assays
Synchronized cells were sonicated to disperse clumps and released into
Lat-A–containing medium for the experiment in Fig. 4. At 1-h intervals, 5
ml of cells from each culture were diluted into 5 ml of fresh YEPD, and
100 ml of the diluted cells were plated onto YEPD plates. Triplicate dilu-
tions were performed for each sample. The plates were incubated at 308C
for 2 d, and the number of colonies was counted. The average 6 standard
deviation was calculated for each triplicate set and is plotted as a percent-
age of the number of colonies on the t 5 0 plates. Error bars indicate stan-
dard deviation. (Where no error bars are seen, the standard deviation was
smaller than the size of the symbols used in the plot.)
Table I. Yeast Strains
Strain Relevant genotype
DLY1 MATa bar1
DLY1028 MATa swe1::LEU2 bar1
JMY1233 MATa/a cap2::URA3/CAP2 swe1::LEU2/SWE1
JMY1169 MATa/a tpm1::URA3/TPM1 swe1::LEU2/swe1::LEU2
JMY1188 MATa/a tpm1::URA3/TPM1
JMY1216 MATa/a sac6::URA3/SAC6 swe1::LEU2/swe1::LEU2
JMY1215 MATa/a sac6::URA3/SAC6
JMY1196 MATa/a pfy1-111:LEU2/pfy1-111:LEU2
swe1::LEU2/SWE1
JMY2-24 MATa myo2-66 swe1::LEU2
JMY2-26 MATa myo2-66
JMY1280 MATa cdc15-2
JMY1281 MATa cdc15-2 GAP:SWE1::HIS2
JMY1341 MATa bar1 GAL1::MIH1::TRP1
JMY1342 MATa bar1 tpm1::URA3 GAL1::MIH1::TRP1
DLY2660 MATa bar1 GAP::SWE1::HIS2
JMY1292 MATa bar1 mih1::LEU2
RSY206 MATa bar1 SWE1-myc::URA3::GAL1::SWE1
RSY255 MATa swe1::LEU2 GAP::SWE1-myc::HIS2::URA3
RSY311 MATa SWE1-myc::URA3The Journal of Cell Biology, Volume 142, 1998 1490
Treatment of Cells with Lat-A
For Lat-A halo assays, 106 cells were spread onto a YEPD plate, and 2 ml
of a 20 mM Lat-A stock solution in DMSO was pipetted onto the center of
the plate. Cells were incubated at 308C for 1 d, and the diameter of the
halo was measured. For cells growing in liquid culture, Lat-A was added
directly to the culture to the desired final concentration.
Results
A Swe1p-dependent Cell Cycle Delay in Cells with a 
Compromised Actin Cytoskeleton
Several mutants in actin cytoskeletal components have
been identified that cause defects in actin organization but
are not sufficiently severe to block bud formation. These
include disruption of CAP2, encoding actin capping pro-
tein (Amatruda et al., 1990, 1992); TPM1, encoding tropo-
myosin (Liu and Bretscher, 1989, 1992); SAC6, encoding
fimbrin (Adams et al., 1991); point mutation of PFY1, en-
coding profilin (Haarer et al., 1990, 1993); and MYO2, en-
coding type V myosin (Johnston et al., 1991). In general,
these mutants grow slowly relative to wild-type cells but
display good cell viability. We reasoned that the morpho-
genesis checkpoint might be delaying cell cycle progres-
sion in these mutants to compensate for the impairment in
bud formation. If this is so, then elimination of checkpoint
function in these cells should uncouple cell cycle progres-
sion from bud formation, leading to a reduction in viability.
To determine whether this was the case, we generated
double mutants between swe1D and the actin cytoskeletal
mutants and examined the growth of double versus single
mutants (Fig. 2). Swe1p is essential for the operation of
the morphogenesis checkpoint, but it has not been found
to play any role in the unperturbed yeast cell cycle: under
standard laboratory growth conditions, swe1D cells grow
at the same rate as their wild-type counterparts and show a
similar cell cycle profile (Fig. 2 A) (Booher et al., 1993; Sia
et al., 1996). Therefore, any effects of Swe1p removal
likely reflect the action of the checkpoint.
Four of the mutants examined (tpm1D, sac6D, pfy1-111,
and myo2-66) displayed a clear reduction in viability when
the morphogenesis checkpoint was crippled by elimination
of Swe1p (Fig. 2 B). This strongly suggests that the actin
perturbations caused by the mutants triggered the check-
point response, as confirmed below.
Intriguingly, the degree of growth benefit provided
by Swe1p varied depending on the growth temperature, in
a mutant-specific manner. The difference between the
growth of different mutants in combination with swe1D
was most extreme at the temperatures shown in Fig. 2 B
but was often reduced at other (78C higher or lower) tem-
peratures. In the most dramatic example, growth of myo2-
66 swe1D cells was impaired relative to myo2-66 cells at
298C, but not at 288C (Fig. 2 B). This was unexpected be-
cause the strain grows slowly and has impaired actin orga-
nization at both temperatures. One problem in interpret-
ing growth assays for very sick strains is the accumulation
of suppressor mutations. We attempted to avoid this prob-
lem by picking fresh colonies from tetrad dissection plates
(see Materials and Methods) as the starting cells for the
spot assays shown in Fig. 2 B, but we cannot rule out the
possibility that suppressors were present in some of our as-
says, leading to the greater apparent health of the double
mutants at some temperatures. However, these data sug-
gest that the checkpoint is not capable of protecting the
mutants at all temperatures, a point we will return to in the
Discussion.
The cap2D mutation did not cause a marked growth de-
fect at any temperature tested in our strain background,
suggesting that bud formation was not slowed sufficiently
to create a requirement for the checkpoint in this strain
(Fig. 2 B).
Figure 2. Requirement for Swe1p in cells with a compromised ac-
tin cytoskeleton. (A) Spot assays of wild-type (DLY1) and swe1::
LEU2 (DLY1028) cells at the indicated temperatures. No differ-
ence in the growth rate of the two strains was observed at any of
the temperatures tested. (B) Spot assays of the indicated mutants.
Each pair of strains (SWE1 vs. swe1::LEU2) was compared on
the same plate, but different pairs were incubated for different
times at several temperatures, as indicated, and cannot be di-
rectly compared with each other. A one degree difference in tem-
perature has a dramatic effect on the importance of Swe1p in
temperature-sensitive myo2-66 cells, although growth defects are
observed in the myo2-66 strain at both 28 and 298C.McMillan et al. Yeast Morphogenesis Checkpoint 1491
The simplest interpretation of these results is that de-
fects in actin cytoskeletal organization result in activation
of the morphogenesis checkpoint, which aids the growth of
the mutants by delaying mitosis until a suitable bud has
been formed. To test this, we monitored cell cycle kinetics
in synchronized mutant strains (Fig. 3). myo2-66 and
myo2-66 swe1D strains were arrested in G1 using a-factor
at 238C and then released at 308C (the restrictive tempera-
ture, at which bud formation was blocked). As shown in
Fig. 3 A, myo2-66 cells displayed a delay in nuclear divi-
sion relative to myo2-66 swe1D cells. We could not apply
the same protocol to the other mutants because it was not
possible to culture the swe1D double mutants without rap-
idly accumulating suppressor mutations. To circumvent
this problem, we integrated a GAL1::MIH1 construct into
wild-type and tpm1D mutant strains. This construct directs
overexpression of Mih1p (the phosphatase that reverses
the Cdc28p phosphorylation catalyzed by Swe1p; Russell
et al., 1989) in cells grown on galactose medium, but not in
cells grown on dextrose or sucrose as carbon source. Thus,
we could conditionally counteract Swe1p activity by cul-
turing the cells on galactose. Cells were grown in sucrose
media, synchronized in G1 with a-factor at 308C, and re-
leased into dextrose- or galactose-containing media (Fig. 3
B). The tpm1D strain displayed a distinct delay of bud for-
mation relative to the wild-type control, in both dextrose
and galactose media, as expected. While on dextrose,
tpm1D cells also delayed nuclear division (Fig. 3 B, com-
pare top two panels), on galactose this delay was elimi-
nated (Fig. 3 B, compare bottom two panels). The resulting
rapid nuclear division in cells that were compromised for
bud formation led to the accumulation of unbudded binu-
cleate cells (Fig. 3 C). Thus, myo2-66 and tpm1D mutants
experienced a cell cycle delay resulting from Cdc28p ty-
rosine phosphorylation (reversible by Swe1p elimination
or Mih1p overexpression). Together with the results from
Fig. 2, these data suggest that perturbation of actin organi-
zation triggers the morphogenesis checkpoint to produce a
Swe1p-dependent delay of the cell cycle, which provides
time for cells to form a bud before undergoing nuclear di-
vision.
Lat-A Triggers a Swe1p-dependent Delay of
Nuclear Division
The drug Lat-A binds to monomeric actin and prevents
actin polymerization (Ayscough et al., 1997). Drubin and
co-workers have recently shown that Lat-A inhibits yeast
growth in a concentration-dependent manner (Ayscough
et al., 1997). Selected mutations in the ACT1 gene, encod-
ing actin, confer Lat-A resistance, confirming that growth
inhibition is due to actin perturbation (Ayscough et al.,
1997). Treatment of yeast cells with 0.1 mM Lat-A results
in rapid (5–10 min) and complete depolymerization of
F-actin (Fig. 4 A and Ayscough et al., 1997). We synchro-
nized wild-type and swe1D cells in G1 using a-factor and
Figure 3. Checkpoint-induced
delay of nuclear division in
myo2-66 and tpm1D mutants.
(A) Kinetics of nuclear divi-
sion in myo2-66 (JMY2-26)
and  myo2-66 swe1::LEU2
(JMY2-24) cells synchro-
nized in G1 with a-factor at
238C and released into fresh
YEPD at 308C. (B) Wild-
type (JMY1341) and tpm1D
(JMY1342) strains contain-
ing the inducible GAL1::
MIH1 construct were grown
in YEPS (sucrose-contain-
ing) media at 308C and ar-
rested with a-factor for 2.5 h.
Dextrose (top two panels) or
galactose (bottom two pan-
els) was added to a final con-
centration of 2%, and the in-
cubation was continued for a
further 1.5 h. At this point,
the cells were homogeneously
arrested in G1 and did (galac-
tose) or did not (dextrose)
overexpress Mih1p. Cells
were harvested by centrifuga-
tion and resuspended in fresh
YEPD (top panels) or YEPG
(galactose; bottom panels) at
308C. The kinetics of bud
formation (open circles) or
nuclear division (closed circles) were determined at different times. (C) The percentage of cells that became binucleate without
forming a bud is shown for the same cells in B, at the 2-h time point.The Journal of Cell Biology, Volume 142, 1998 1492
then washed out the a-factor and added 0.1 mM Lat-A
(Fig. 4 B). Flow cytometric analysis demonstrated that
DNA replication was complete by 60 min in both strains
(data not shown). However, microscopic analysis revealed
that wild-type cells treated with Lat-A did not undergo nu-
clear division for the entire 7-h time course of the experi-
ment (Fig. 4 B). This block to nuclear division was Swe1p
dependent because swe1D cells completed nuclear division
by 2 h (Fig. 4 B). Thus, like the actin-perturbing mutants,
Lat-A treatment triggers the morphogenesis checkpoint.
SWE1 Protects Cells from Transient Exposure to Lat-A
To assess whether the Swe1p-mediated cell cycle arrest
was effective in maintaining cell viability during Lat-A
treatment, cells from the same experiment as Fig. 4 B were
assayed for viability (i.e., the ability to form colonies) after
different times of exposure to Lat-A (Fig. 4 C). The results
in this experiment show that wild-type cells retained good
viability (.75%) even after 7 h of Lat-A treatment. In
contrast, 50% of the swe1D mutant cells lost the ability to
form colonies after only 1 h in Lat-A (Fig. 4 C). This tim-
ing may seem surprisingly rapid since swe1D cells under-
went nuclear division between 1 and 2 h after release from
pheromone arrest. However, we have confirmed the ob-
servation of Ayscough et al. (1997) that actin structures
are not recovered immediately upon Lat-A removal, but
rather take z1 h to reform and become polarized. Thus, 1 h
Figure 4. Swe1p-dependent
cell cycle arrest in Lat-A–treated
cells. (A) F-actin organization
in cells exposed to Lat-A. Ex-
ponentially growing wild-
type (DLY1) cells were ex-
posed to 0, 10, or 100 mM
Lat-A for 1 h at 308C and
then fixed and stained with
rhodamine-phalloidin. No ac-
tin structures were seen in
cells treated with 100 mM
Lat-A (equal exposures are
shown for all fluorescence
panels). Cortical actin patches
were readily detected in cells
treated with 10 mM Lat-A
and were frequently polar-
ized towards the presump-
tive bud site in unbudded
cells and the tip of the bud in
small-budded cells, but no ca-
bles were seen. (B) Kinetics
of nuclear division for wild-
type (DLY1) and swe1D
(DLY1028) cells after release
from a-factor–induced G1 ar-
rest into fresh media contain-
ing 100 mM Lat-A. (C) Via-
bility of the same cells in B.
Viability was assayed by the
ability of the cells to give rise
to colonies once the Lat-A
was washed out, as described
in Materials and Methods.
(D) Lat-A halo assay. 2 ml of
20 mM Lat-A was spotted
onto YEPD plates spread
with wild-type (DLY1) or
swe1::LEU2 (DLY1028) cells.
The diameter of the zone of
no growth, or “halo,” was
12 mm for both strains. Bar,
5 mm. McMillan et al. Yeast Morphogenesis Checkpoint 1493
of Lat-A exposure corresponds to closer to 2 h of absent
or disorganized F-actin, by which time the swe1D cells had
completed nuclear division.
Although 50% of the swe1D cells lost viability rapidly in
this experiment, the remaining cells were apparently able
to withstand prolonged exposure to Lat-A, with only a
gradual loss of viability (Fig. 4 C). We are currently mysti-
fied by this heterogeneity in the response of the swe1D
population to Lat-A and cannot explain why some cells
live while others die rapidly. However, it is worth bearing
in mind that the viability assay we used monitors the abil-
ity of cells to give rise to colonies in a very nutrient-rich
environment and in isolation from other cells. It seems
likely that if wild-type and swe1D cells were mixed in a
competitive environment, a large majority of the swe1D
cells would be at a severe disadvantage after even a brief
Lat-A exposure.
During the course of these studies, we discovered that
cells arrested using higher doses of pheromone (100 ng/ml
versus the 20 ng/ml used in Fig. 4; note that all strains are
bar1D) were very slow to recover from the G1 arrest.
(Data not shown; we speculate that the Lat-A prevents en-
docytosis of pheromone-bound receptors and hence re-
covery from pheromone arrest.) Under these circum-
stances, wild-type and swe1D cells retained viability to a
similar extent (data not shown). This suggests that the via-
bility loss observed for swe1D cells in Fig. 4 C is a conse-
quence of continued cell cycle progression and does not
reflect some other role for Swe1p.
SWE1 Does Not Protect Cells from Continuous 
Exposure to Low Doses of Lat-A
The sensitivity of yeast strains to Lat-A is easily measured
using a “halo” assay, in which a spot of concentrated Lat-A
is placed in the middle of a lawn of yeast cells. The drug
diffuses out from this spot and creates a halo, or zone of
growth inhibition, in which cells cannot proliferate; the
size of the halo reflects the sensitivity of the strain to Lat-A
(Ayscough et al., 1997). To test whether the morphogene-
sis checkpoint would allow wild-type cells to withstand a
greater degree of continuous actin perturbation, we per-
formed Lat-A halo assays on isogenic wild-type and swe1D
strains. At the concentration of Lat-A present at the edge
of the halo, bud formation is presumably delayed but not
blocked; at these doses, the checkpoint would be expected
to maintain coordination between the impaired bud for-
mation and cell cycle progression, permitting cell prolifer-
ation. If this were the case, swe1D cells would be unable to
maintain that coordination and should therefore display a
larger halo. Unexpectedly, the size of the halo was identi-
cal for the two strains (Fig. 4 D), showing that Swe1p does
not protect cells from continuous exposure to low doses of
Lat-A.
The Checkpoint Delay of Nuclear Division Is Not 
Commensurate with the Delay of Bud Formation at 
Low Doses of Lat-A
Why does the checkpoint-induced G2 delay not help cells
to survive continuous exposure to Lat-A? To address this
question we repeated the synchrony experiment using
lower doses of Lat-A (Fig. 5). At these concentrations,
cells retained the ability to polymerize and (at the lower
doses) to polarize actin (Fig. 4 A), and bud formation was
delayed to varying extents (Fig. 5 A). As expected, Lat-A–
treated cells displayed a delay in nuclear division com-
pared with untreated cells, and the duration of the delay
increased with the dose of Lat-A (Fig. 5). Surprisingly,
however, the delay of nuclear division was not commensu-
rate with the delay of bud formation. As the dose of Lat-A
was increased, the time between bud formation and nu-
clear division decreased, until the events were reversed
and cells became binucleate before they could form a visi-
ble bud (see Fig. 5 B, top). Presumably, this explains why
the checkpoint fails to protect cells from low doses of Lat-A:
even with an active checkpoint, the cell cycle is insuffi-
ciently delayed to cope with the delay in bud formation.
As expected, the delay of nuclear division was Swe1p
dependent at all doses of Lat-A (Fig. 5 B, middle). One
consequence of this was that low doses of Lat-A, which
still permitted bud formation in wild-type cells, were suffi-
cient to block bud formation in swe1D cells (Fig. 5 B, com-
pare top two panels). Previous work has established that
the cyclin/Cdc28p complexes that promote mitosis also
promote actin depolarization during the cell cycle; inhibi-
tion of these complexes by Swe1p maintains a cyclin/
Cdc28p configuration that promotes actin polarization
(Lew and Reed, 1993). Thus, in wild-type cells exposed to
low doses of Lat-A, Swe1p delays the cell cycle at a stage
when cyclin/Cdc28p complexes promote actin polariza-
tion, and given sufficient time, the actin cytoskeleton can
polarize and build a bud. In swe1D cells, the actin cytoskel-
eton is similarly competent to build a bud but is not given
sufficient time to do so before the cell cycle progresses to a
point when cyclin/Cdc28p complexes now promote actin
depolarization, and bud formation does not occur.
The duration of the cell cycle delay in Lat-A was deter-
mined by Mih1p (Fig. 5 B, bottom). In mih1D cells, equiva-
lent doses of Lat-A caused greatly prolonged delays of nu-
clear division compared with wild-type cells, and the delay
between bud formation and nuclear division increased
with Lat-A dose, rather than decreasing as in the wild
type. This shows that Mih1p terminates the cell cycle delay
in wild-type cells exposed to Lat-A, and that termination is
not dependent on bud formation. As discussed below, this
finding is inconsistent with a model in which the check-
point simply delays nuclear division until a bud has been
formed.
Lat-A Can Arrest Nuclear Division in Cells That Have 
Already Formed a Bud
In the synchrony experiments described above, the check-
point was triggered by perturbation of actin in unbudded
cells. Thus, bud formation was itself delayed or inhibited,
and it was not clear from these experiments whether the
actin perturbation itself or the consequent delay of bud
formation was responsible for triggering the checkpoint.
To distinguish between these options, we wished to deter-
mine whether actin perturbation would trigger the check-
point in cells that had already formed a bud. To test this,
we treated asynchronous wild-type and swe1D populations
with 0.2 mM Lat-A for 3 h (approximately two doubling
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budded cells in the wild-type population did not undergo
nuclear division, while many of the swe1D cells did (Fig. 6
A). Budded wild-type cells displayed a mixed response:
56% contained two nuclei, while 44% contained a single
nucleus (Fig. 6 A). In general, cells with single nuclei had
small buds, while cells with two nuclei had larger buds. In
contrast, almost all of the budded swe1D cells contained
two nuclei (Fig. 6 A). This experiment demonstrates that
the checkpoint can respond to actin perturbation even af-
ter cells have formed a bud.
Some of the cells in this experiment underwent cytoki-
nesis during the 3 h time course (Fig. 6 A), making it diffi-
cult to determine the size of the subset of budded cells that
actually arrested before anaphase upon Lat-A treatment.
To circumvent this problem, we introduced the cdc15-2
mutation into the strain background. At the restrictive
temperature, this mutation prevents cytokinesis (Pringle
and Hartwell, 1981), which allowed us to accurately quan-
titate the proportion of cells that underwent nuclear divi-
sion after Lat-A addition (Fig. 6 B, left). Asynchronous
populations of cdc15-2 cells were grown at 248C and
shifted to 378C. Lat-A was added to 0.2 mM 10 min after
the temperature shift, and the cells were incubated for a
further 3 h. Under these conditions, unbudded cells could
not form a bud (because of the Lat-A), and budded cells
could not undergo cytokinesis (because of the cdc15-2 mu-
tation). Unbudded cells arrested with a single nucleus, as
expected. Of the budded cells, 34% of the pre-anaphase
cells arrested with a single nucleus (Fig. 6 B). Thus, the
ability to respond to actin perturbation is not maintained
throughout the budded portion of the cell cycle: only
about one third of the budded cells (probably representing
the cells with the smallest buds; see below) underwent a
Swe1p-dependent G2 arrest upon Lat-A addition.
Figure 5. The checkpoint de-
lay at low doses of Lat-A. (A)
Kinetics of bud formation
and nuclear division in wild-
type cells (DLY1) after re-
lease from a-factor–induced
G1 arrest into fresh media
containing the indicated con-
centrations of Lat-A. (B)
(Top) The data from A is re-
plotted as the time taken for
50% of the cells to form buds
(black bars) or undergo nu-
clear division (gray bars) at
the indicated concentrations
of Lat-A. The middle and
bottom panels represent simi-
lar plots from identical ex-
periments with swe1::LEU2
(DLY1028,  middle) and
mih1:LEU2 (JMY1292, bot-
tom) strains.McMillan et al. Yeast Morphogenesis Checkpoint 1495
Swe1p Accumulates Periodically during the Cell Cycle
Why do budded cells lose the capacity to arrest cell cycle
progression in response to actin perturbation? One possi-
bility is suggested by the observation that SWE1 mRNA
accumulates periodically during the cell cycle, with a peak
in late G1 (Lim et al., 1996; Ma et al., 1996; Sia et al.,
1996). If the presence of Swe1p were restricted to cells that
were at an early stage of the cell cycle, then the population
of cells that arrested in response to Lat-A may correspond
to the subset of cells that contained Swe1p. Later in the
cell cycle, there would be insufficient Swe1p to promote
cell cycle arrest, even if the Lat-A were to trigger the up-
stream components of the checkpoint pathway. In this sce-
nario, the checkpoint “detector” would detect the actin
perturbation at any stage of the cell cycle, but would only
cause cell cycle arrest in cells that contained the “receiver”
of the checkpoint signal, Swe1p.
To determine whether Swe1p accumulation was indeed
periodic during the cell cycle, we generated an epitope-
tagged version of SWE1, SWE1-myc, integrated at the
SWE1 locus under the control of the SWE1 promoter (see
Materials and Methods). Control experiments indicated
that this construct retained full activity (Sia, R.A.L.,
E.S.G. Bardes, and D.J. Lew, manuscript submitted for
publication). The monoclonal 9E12 (anti-myc) antibody
recognized a band of z180 kD in cells expressing Swe1p-
myc, but not in cells lacking the tagged construct (Fig. 7 B,
left two lanes). Cells containing tagged Swe1p were syn-
chronized using an a-factor arrest/release protocol, and
the abundance of Swe1p was monitored by Western blot-
ting through the cell cycle (Fig. 7). Swe1p accumulation
Figure 6. Budded cells can respond to Lat-A. (A) Wild-type
(DLY1) and swe1::LEU2 (JMY3-3) cells were exposed to 200
mM Lat-A for 3 h at 308C. The percentage of unbudded (UB) and
budded (B) cells containing one nucleus (white bars) or two nu-
clei (black bars) were calculated before and after Lat-A treat-
ment. The increase in the percentage of unbudded cells is due to
cytokinesis of some of the budded cells, which subsequently ar-
rest as unbudded cells. (B) Asynchronous populations of temper-
ature-sensitive cdc15 (JMY1280) and cdc15 GAP::SWE1 (JMY1281)
cells were treated as in A, except that cells were shifted to the
nonpermissive temperature of 378C 10 min before the addition of
Lat-A to prevent cytokinesis (a phenotype of the cdc15 allele).
Figure 7. Swe1p accumulation is periodic during the cell cycle.
(B)  Left two lanes, lysates of asynchronous wild-type cells
(DLY1,  No myc tag) or cells containing an integrated SWE1-
myc12 (RSY206) were separated by SDS-PAGE and immuno-
blotted with the 9E10 monoclonal anti-myc antibody (upper
panel) or a monoclonal anti-PSTAIRE antibody as a loading con-
trol (lower panel; two proteins are recognized by this antibody in
yeast lysates—the upper band corresponds to Pho85p and the
lower band to Cdc28p). Right lanes, similar immunoblots of the
SWE1-myc12 (RSY206) strain at the indicated time points after
release from a-factor–induced G1 arrest into fresh media. The ki-
netics of bud formation and nuclear division for the first cell cycle
in the same experiment are plotted in A.The Journal of Cell Biology, Volume 142, 1998 1496
was periodic during the cell cycle, rising at the time of bud
emergence and declining again before nuclear division. This
pattern of accumulation is consistent with the previously
described pattern of SWE1 transcriptional regulation and
suggests that Swe1p is a moderately unstable protein.
Periodic Swe1p Expression Limits Checkpoint Action 
during the Cell Cycle
To determine whether the periodic expression of Swe1p
was responsible for the decrease in checkpoint efficacy
during the budded portion of the cell cycle, we generated a
strain in which SWE1 transcription was constitutive
throughout the cell cycle by integrating three to four cop-
ies of a GAP::SWE1 allele into a wild-type strain at the
HIS2 locus (Sia et al., 1996; note that although mRNA lev-
els driven by this construct are constant through the cell
cycle, posttranslational regulation of Swe1p might still oc-
cur). Quantitative immunoblotting of myc-tagged Swe1p
driven by this construct (Fig. 8 C) in asynchronous cells
suggests that it expresses only 30% as much Swe1p as the
wild-type gene. Thus, three to four copies (in addition to
the wild type) would lead to approximately twofold over-
expression of Swe1p (comparing asynchronous popula-
tions). The doubling time and cell cycle profile of the
GAP::SWE1-containing strain was indistinguishable from
that of wild-type cells (Fig. 8 A), indicating that this degree
of Swe1p overexpression was insufficient to delay nuclear
division in unperturbed cells.
Wild-type and GAP::SWE1-containing strains were syn-
chronized with a-factor and treated with Lat-A at differ-
ent times after release from the arrest. In this experiment,
bud formation occurred at 10–20 min, and nuclear division
occurred at 40–50 min (Fig. 8 A). At the intervening times
(20, 30, and 40 min) when cells had formed buds but not
yet undergone nuclear division, aliquots of cells were
treated with 0.1 mM Lat-A and subsequently fixed at 90
min. By this time, untreated cells had completed nuclear
division (Fig. 8 A). However, a subset of the Lat-A–
treated cells arrested without undergoing nuclear division
(Fig. 8 B). In the wild-type cells, only 50% of budded cells
arrested in response to Lat-A even at the 20 min stage
when cells had formed small buds, and the proportion of
responding cells decreased as cells progressed through the
cell cycle (Fig. 8 B, white bars). In contrast, 99% of the
budded GAP::SWE1-containing cells arrested in response
to Lat-A at the 20 min stage (Fig. 8 B, black bars). Fewer
cells responded at later times, but the fraction of respond-
ing cells remained much higher than in the wild type at all
times. This experiment demonstrates that cells with larger
buds can detect the actin perturbation caused by Lat-A
and respond by arresting nuclear division if sufficient
Swe1p is present. In wild-type cells, the ability to mount a
response decreases shortly after bud formation because
Swe1p levels decline.
We have confirmed these observations in asynchronous
populations of cdc15-2 cells expressing GAP::SWE1 (Fig.
6 B, right). While only 34% of budded pre-anaphase cells
expressing the wild-type SWE1 arrested in response to
Lat-A, 85% of the budded pre-anaphase cells expressing
the constitutive GAP::SWE1 arrested before nuclear divi-
sion (Fig. 6 B). These experiments strongly suggest that
Lat-A can trigger a Swe1p-dependent G2 arrest through
most of the cell cycle, provided that sufficient Swe1p is
present.
Discussion
The experiments reported in this paper allow us to draw
Figure 8. The checkpoint response in budded cells from strains
expressing periodic or constitutive Swe1p. (A) Kinetics of bud
formation and nuclear division in wild-type cells (DLY1, squares)
and cells containing three to four copies (determined by South-
ern blots) of an integrated GAP::SWE1 construct (DLY2660, cir-
cles) after release from a-factor–induced G1 arrest into fresh me-
dia. (B) At the indicated times of the synchrony experiment
shown in A, 100 mM Lat-A was added to aliquots of the culture,
and the incubation was continued until t 5 90 min. The cells were
fixed and stained to visualize nuclei, and the percentage of bud-
ded cells that remained mononucleate (i.e., were arrested in re-
sponse to Lat-A) is plotted. White bars, wild-type cells; black
bars, GAP::SWE1 cells. (C) A strain containing a single myc-
tagged GAP::SWE1 expresses 30 6 10% (standard deviation) as
much Swe1p as a strain containing myc-tagged SWE1 on its own
promoter, as quantitated by scanning densitometry of the dot im-
munoblots shown (see Materials and Methods for details).McMillan et al. Yeast Morphogenesis Checkpoint 1497
three novel conclusions regarding the morphogenesis check-
point in budding yeast. First, the checkpoint monitors de-
fects at the level of actin organization. Our data cannot be
accommodated by models in which the checkpoint simply
monitors upstream polarity establishment functions or
downstream events such as bud formation or bud growth.
The possibility remains that the checkpoint might monitor
multiple processes in addition to actin organization, al-
though there is currently no need to invoke such complex-
ity to explain the available data. Second, the checkpoint
can detect perturbation of actin integrity at any stage of
the cell cycle between Start and nuclear division. Third,
the efficacy of the checkpoint in responding to actin per-
turbation by arresting cell cycle progression is limited to a
critical window of the cell cycle (the time of initial bud
emergence and growth) by the periodic expression of the
checkpoint effector, Swe1p. As a consequence of these
features, environmental insults that perturb actin organi-
zation will only delay nuclear division in cells that have
not yet constructed a mature bud, and the effect of the
checkpoint is to couple nuclear division to successful bud
formation.
The Morphogenesis Checkpoint Responds to 
Perturbation of Actin Organization
We have previously shown that perturbation of cell polar-
ity in yeast triggers a morphogenesis checkpoint that de-
lays nuclear division (Lew and Reed, 1995a; Sia et al.,
1996). In this report, we have investigated the effects of
perturbing the actin cytoskeleton itself, rather than polar-
ity establishment functions, on cell cycle progression. We
found that both mutation of genes encoding actin-associ-
ated proteins and the actin-depolymerizing drug Lat-A
produced a delay or arrest of the cell cycle before nuclear
division. The cell cycle delay was dependent upon Swe1p,
arguing that it was a consequence of the morphogenesis
checkpoint. These findings have important implications
for the structures that might be monitored by the check-
point. Cells lacking F-actin altogether are still able to po-
larize Cdc42p, septins, and other cortical proteins (Ay-
scough  et al., 1997). Thus, the fact that actin perturbations
trigger the checkpoint suggests that the checkpoint does
not simply monitor polarity establishment or septin assem-
bly. More likely, the checkpoint monitors the actin cyto-
skeleton itself, or perhaps a process that is tightly linked to
correct actin organization.
One process that depends on polarized actin is polarized
secretion and/or cell wall deposition. Like the actin pertur-
bations described here, mutation of BED1 (also called
MNN10 and SLC2) created a requirement for the mor-
phogenesis checkpoint (Mondesert and Reed, 1996). The
bed1 mutant impaired protein glycosylation and displayed
a pronounced delay in bud formation (Dean and Poster,
1996; Mondesert and Reed, 1996). Defects in actin organi-
zation were apparent in one bed1 strain, but actin was ap-
parently normal in bed1 mutants from another strain back-
ground (Karpova et al., 1993; Mondesert and Reed, 1996).
Thus, it is unclear whether bed1 mutants trigger the check-
point through an effect (which can be quite subtle) on ac-
tin organization itself or through effects on a downstream
process involving protein glycosylation. A similar uncer-
tainty exists for the interpretation of other mutants affect-
ing protein glycosylation and secretion that were isolated
in the same genetic screen as bed1 (Mondesert et al.,
1997). However, these studies do support our conclusion
that either actin organization itself or a process that de-
pends on proper actin organization is monitored by the
checkpoint.
The most obvious actin-dependent cell cycle events that
the checkpoint could respond to are the emergence or
growth of the bud. For instance, there may be some way to
detect the presence of a bud (or perhaps a neck, which
would be unique to budded cells) or to assess the size or
maturity of a bud. If the checkpoint were to monitor bud
emergence or bud size, then once a suitable bud had been
formed, perturbation of actin would no longer be expected
to have any effect on cell cycle progression. However, we
found that in cells expressing a constitutive level of SWE1
mRNA, actin perturbation was in fact able to halt cell cy-
cle progression even when cells had successfully con-
structed a large bud. This demonstrates that the structure
monitored by the checkpoint is still actin dependent after
a large bud has been formed, arguing that the checkpoint
does not simply monitor the presence or size of the bud.
Does the Checkpoint Monitor Completion of a Cell 
Cycle Event?
Complete actin depolymerization blocked cell cycle pro-
gression, while less severe actin perturbations produced
G2 delays of various lengths. This raises the question of
what determines the duration of the G2 delay in response
to different perturbations. One possibility is that the dura-
tion of the delay simply reflects the time needed to com-
plete an actin-dependent cell cycle event, which takes
more or less time depending on the degree of perturba-
tion. Termination of the checkpoint delay then occurs
when the hypothetical event is complete. Although the de-
lays in response to some perturbations (e.g., tpm1D mu-
tants) were sufficient to permit bud formation, we found
that in cells treated with some doses of Lat-A, the check-
point delay was terminated before most cells could make a
bud. Similarly, a complete block of cell polarity (imposed
using temperature-sensitive cdc24 or cdc42 mutants) pro-
duces only a transient delay in nuclear division (Lew and
Reed, 1995a; Sia et al., 1996). Thus, if termination of the
delay reflects completion of some event, then that event
can be completed in the absence of detectable polarity in
unbudded cells. As mentioned above, actin perturbation
can produce a delay even in cells with large buds. Thus, to
accommodate our observations, the hypothetical actin-
dependent event monitored by the checkpoint would have
to occur very late in the unperturbed cell cycle but would
be attainable even in unbudded cells. It is difficult to imag-
ine an event that meets these criteria.
An alternative hypothesis is that instead of monitoring
completion of a cell cycle event, the checkpoint continu-
ously monitors the status of the actin cytoskeleton. Just as
the DNA damage checkpoint continuously monitors DNA
integrity rather than any particular cell cycle event, we
propose that the morphogenesis checkpoint monitors the
integrity or organization of the actin cytoskeleton. Be-
cause actin integrity is subject to perturbation at any stageThe Journal of Cell Biology, Volume 142, 1998 1498
of the cell cycle, it is easy to incorporate the observation
that actin perturbations can be detected in large-budded
as well as unbudded or small-budded cells.
Duration of the Checkpoint Delay: The Role
of Adaptation
If the checkpoint responds to disruption of cytoskeletal in-
tegrity, what terminates the checkpoint delay? Since nu-
clear division in mutants with disrupted cell polarity oc-
curred with no apparent recovery of cell polarity, we
proposed that the checkpoint displays adaptation (Sia et
al., 1996). Adaptation has also been described for the
DNA damage checkpoint (Sandell and Zakian, 1993; Toc-
zyski  et al., 1997). To accommodate the data reported
here, we extend this idea by supposing that mild perturba-
tion of actin organization leads to rapid adaptation, while
more severe perturbations cause progressively slower ad-
aptation. Both in the case of mutants disrupting cell polar-
ity (Sia et al., 1996) and wild-type cells exposed to Lat-A
(Fig. 5 B), termination of the checkpoint delay requires
the phosphatase Mih1p.
The adaptation hypothesis does not link termination of
the checkpoint delay to completion of a specific cell cycle
event. This makes it much easier to explain why some per-
turbations apparently trigger appropriate delays (i.e., the
cell cycle delay matches the delay in bud formation) while
others (such as low doses of Lat-A) do not. In addition,
the variable success of the checkpoint in terms of matching
the cell cycle delay to the delay of budding may explain
why the presence of Swe1p improved the viability of mu-
tants with impaired actin organization at some, but not all,
temperatures. Presumably, the checkpoint evolved to cope
with physiological insults (such as temperature or osmo-
larity changes) that affect the cytoskeleton. The adapta-
tion process would provide appropriate delays for those
perturbations, but not necessarily for the artificial pertur-
bations we have tested here.
Periodic SWE1 Transcription Limits Checkpoint Action 
during the Cell Cycle
Transcription of SWE1 is periodic during the cell cycle,
with a peak in late G1 (Lim et al., 1996; Ma et al., 1996; Sia
et al., 1996). Furthermore, Swe1p accumulation is also pe-
riodic during the cell cycle (Fig. 7). In contrast, Mih1p
abundance is constant through the cell cycle (McMillan,
J.N., and D.J. Lew, unpublished). In the unperturbed cell
cycle, G2 cyclin/Cdc28p complexes (the Swe1p substrates)
do not accumulate until G2, when Swe1p levels are de-
creasing, and Swe1p therefore has little effect on the cell
cycle. The situation is very different in fission yeast, where
wee1 (homologous to SWE1) transcription is constitutive
(Aligue et al., 1997) and cdc25 (homologous to MIH1)
transcription is periodic, peaking at G2/M (Moreno et al.,
1990). With that pattern of regulation, wee1 phosphory-
lates and inhibits G2 cyclin/cdc2 complexes as soon as they
accumulate, and cell cycle progression is delayed until
cdc25 accumulates sufficiently to reverse wee1 action.
Thus, different programs of regulated transcription con-
tribute to the very different biological roles of the same
cell cycle regulators in these two organisms.
The DNA damage checkpoint can delay the cell cycle at
multiple stages, depending on when the damage is in-
curred. This helps to prevent attempts to replicate or seg-
regate damaged DNA, with potentially catastrophic con-
sequences. In contrast, the morphogenesis checkpoint
appears to delay the cell cycle specifically in G2, which
presumably serves to prevent nuclear division in cells lack-
ing a large enough bud. Once a medium-sized bud has
formed, there would no longer be any detriment to going
ahead with nuclear division, and wild-type cells no longer
delay the cell cycle in response to actin perturbation. We
have shown that cells in which SWE1 transcription has
been rendered constitutive (rather than being limited to
late G1 and early S phase) delay the cell cycle in response
to actin perturbation even in larger-budded cells. Thus,
periodic transcription of SWE1 limits the window within
the cell cycle during which actin perturbation can halt cell
cycle progression. The consequence of this limitation is
that the checkpoint delay is only invoked by the cells that
still need more time to complete bud formation.
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